amx0035
Showing 1 - 9 of 9
Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases Trial (AMX0035, Placebo)
Not yet recruiting
- Progressive Supranuclear Palsy
- +3 more
- AMX0035
- Placebo
- (no location specified)
Nov 3, 2023
Wolfram Syndrome Trial (AMX0035)
Not yet recruiting
- Wolfram Syndrome
- AMX0035
- (no location specified)
Dec 22, 2022
Amyotrophic Lateral Sclerosis, ALS Trial in Boston, Worcester (AMX0035)
Completed
- Amyotrophic Lateral Sclerosis
- ALS
- AMX0035
-
Boston, Massachusetts
- +1 more
Jan 5, 2022
Amyotrophic Lateral Sclerosis Trial in Puerto Rico, United States (AMX0035)
Approved for marketing
- Amyotrophic Lateral Sclerosis
- AMX0035
-
Los Angeles, California
- +20 more
Oct 14, 2022
Amyotrophic Lateral Sclerosis Trial in Worldwide (AMX0035)
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- AMX0035
-
Leuven, Belgium
- +42 more
Jan 20, 2023
Amyotrophic Lateral Sclerosis Trial in United States (AMX0035)
Enrolling by invitation
- Amyotrophic Lateral Sclerosis
- AMX0035
-
San Francisco, California
- +4 more
Jul 20, 2021
Alzheimer Trial in United States (AMX0035, Placebo)
Completed
- Alzheimer Disease
- AMX0035
- Placebo
-
Jacksonville, Florida
- +10 more
Nov 10, 2021
Amyotrophic Lateral Sclerosis Trial in Worldwide (Placebo, AMX0035)
Active, not recruiting
- Amyotrophic Lateral Sclerosis
- Placebo
- AMX0035
-
Phoenix, Arizona
- +68 more
Jan 4, 2023
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neuromuscular Diseases Trial in United States (AMX0035, Placebo)
Completed
- Amyotrophic Lateral Sclerosis
- +7 more
- AMX0035
- Placebo
-
Phoenix, Arizona
- +24 more
Jul 20, 2021